Family-Participatory Early Rehabilitation in Critically Ill Patients
Effect of an Internet-Based, Mobile Terminal-Supported, Family-Participatory Early Rehabilitation Model on Sleep Improvement and Stigma Prevention in Critically Ill Patients: A Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hebei
-
Shijiazhuang, Hebei, China, 050000
- The First Hospital of Hebei Medical University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age ≥ 18 years
- Expected ICU stay of more than 48 hours
- Hemodynamic stability (mean arterial pressure 65-110 mmHg with no or low-dose vasopressor support)
- Stable respiratory status (PaO2/FiO2 > 200 mmHg, SpO2 ≥ 88%)
- Richmond Agitation-Sedation Scale (RASS) score ≥ -2
- Having at least one family member willing and able to participate
Exclusion Criteria:
- Unstable cardiovascular conditions (e.g., acute coronary syndrome, malignant arrhythmia)
- Acute neurological injury with unstable intracranial pressure
- Unstable fractures or spinal cord injury
- Active, uncontrolled bleeding
- Pre-existing severe psychiatric disorders or dementia
- Inability to provide consent and no available legal surrogate
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Internet-Based, Family-Participatory Early Rehabilitation (IFPER) Group
In addition to standard care, patients received a structured, family-participatory early rehabilitation program guided by the "7P Rehabilitation Pyramid Model."
Trained family members used a mobile application to assist with activities including Position Management, Pain & Sedation Management, Physiotherapeutics, Pulmonary Rehabilitation, Psychological Rehabilitation, Performance Rebuilding, and fostering Purpose & Belonging.
The sessions were conducted for 30-45 minutes, twice daily.
|
A structured, multi-component rehabilitation program facilitated by trained family members using a mobile application for guidance and communication, based on the "7P Rehabilitation Model."
|
|
Active Comparator: Standard Care Group
Patients received routine ICU care, which included standard medical and supportive care, daily assessments, sedation management, pain control, nutritional support, and standard early rehabilitation protocols delivered by the ICU physical therapy team.
|
Routine ICU care including medical support and standard rehabilitation delivered by ICU staff.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Sleep Efficiency
Time Frame: From enrollment through ICU discharge, an average of 10 days
|
Measured by polysomnography (PSG).
Sleep efficiency is calculated as (total sleep time / time in bed) × 100%.
The change is assessed from baseline to the day before ICU discharge.
|
From enrollment through ICU discharge, an average of 10 days
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Social Stigma Score
Time Frame: At ICU discharge, an average of 10 days after enrollment
|
Measured by the Social Stigma in Critical Illness (SSCI) scale.
The scale ranges from 10 to 50.
A higher score indicates a worse outcome (greater perceived stigma).
|
At ICU discharge, an average of 10 days after enrollment
|
|
Procedural Pain Scores
Time Frame: Through ICU stay, an average of 10 days
|
Assessed daily using the Numeric Rating Scale (NRS) for communicative patients and the Critical-Care Pain Observation Tool (CPOT) for non-communicative patients.
The NRS is on a 0-10 scale, and the CPOT is on a 0-8 scale.
For both scales, a higher score indicates a worse outcome (more pain).
|
Through ICU stay, an average of 10 days
|
|
Duration of Mechanical Ventilation
Time Frame: Through ICU stay, an average of 7 days
|
The total number of days a patient requires mechanical ventilation.
|
Through ICU stay, an average of 7 days
|
|
ICU Length of Stay
Time Frame: Through study completion, an average of 10 days
|
The total number of days a patient stays in the ICU.
|
Through study completion, an average of 10 days
|
|
Incidence of Delirium
Time Frame: Through ICU stay, an average of 10 days
|
The percentage of patients who develop delirium, assessed twice daily using the Confusion Assessment Method for the ICU (CAM-ICU).
|
Through ICU stay, an average of 10 days
|
|
Change in Percentage of REM Sleep
Time Frame: From enrollment through ICU discharge, an average of 10 days
|
Change in the percentage of Rapid Eye Movement (REM) sleep, measured by polysomnography (PSG).
|
From enrollment through ICU discharge, an average of 10 days
|
|
Change in Percentage of N1 Sleep
Time Frame: From enrollment through ICU discharge, an average of 10 days
|
Change in the percentage of Stage 1 non-REM sleep, measured by polysomnography (PSG).
|
From enrollment through ICU discharge, an average of 10 days
|
|
Change in Percentage of N2 Sleep
Time Frame: From enrollment through ICU discharge, an average of 10 days
|
Change in the percentage of Stage 3 non-REM (slow-wave) sleep, measured by polysomnography (PSG).
|
From enrollment through ICU discharge, an average of 10 days
|
|
Change in Arousal Index
Time Frame: From enrollment through ICU discharge, an average of 10 days
|
Change in the number of arousals or awakenings per hour of sleep, measured by polysomnography (PSG).
|
From enrollment through ICU discharge, an average of 10 days
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2022S00433
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.